Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Botulinum-A Toxin for Detrusor Hyperreflexia in SCI
NCT00262496Phase 2Withdrawn
- Sponsor
- United States Department of Veterans Affairs
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of botulinum toxin type A in neurogenic detrusor overactivity (NDO) and urinary incontinence (UI) (2 arms), sponsored by United States Department of Veterans Affairs. Status: withdrawn.
02
Drugs
botulinum toxin type A
03
Conditions
neurogenic detrusor overactivity (NDO)urinary incontinence (UI)
Beyond the preview
Go deeper on NCT00262496.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00262496.